Nanomedicine Delivery using Biopolymers for the Treatment of Cancerous Wounds
Main Article Content
Abstract
Biopolymer-based nano drug delivery systems are an emerging and promising strategy for addressing the challenges of cancer treatment and wound healing. These natural nanocarriers are like alginate, chitosan, gelatin, and hyaluronic acid. These nanosystems offer biocompatibility, biodegradability, and reduced toxicity of the therapeutics. The nanoparticles can be loaded with growth factors, which accelerate tissue These provide targeted delivery sites and also modulate the microenvironment of the tissue by sustained drug release and reducing the damage to healthy tissues, thus promoting cancer treatment and wound tissue regeneration in a synergistic manner. Drug delivery system (DDS) technology includes a variety of approaches such as liposomes, nanofibers, and inorganic and lipid nanoparticles. The focus of this chapter is to provide the recent developments in biopolymer-based strategies and their applications for the future prospects for clinical implementation.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journals licensing terms of CC-BY-NC-SA 4.0 speaks that you are free to Share (copy and redistribute the material in any medium or format), Adapt (remix, transform, and build upon the material) under proper terms of Attribution (You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.), NonCommercial (You may not use the material for commercial purposes.), ShareAlike (If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.) and No additional restrictions (You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.)